港鐵(00066.HK)推出手機應用程式「關愛共乘」 支援長者及有需要人士出行
港鐵(00066.HK)宣佈正式推出手機應用程式「關愛共乘」,爲長者及有特別需要的乘客在乘搭港鐵時可實現「智慧出行」。
首階段關愛共乘將提供方便長者使用的「行程指南(簡易版)」及供視障人士專用行的「站內導航」共兩大功能,其中站內導航將率先在會展站試行。
港鐵預計,明年下半年將在應用程式內推出更多迎功能,例如爲行動不便的乘客提供預約輪椅活動摺板服務、爲聽障人士提供非緊急求助服務,以及查閱車站升降機的實時運作情況等。
另外,港鐵宣佈今年將繼續支持長者日,於本月20日(星期日)爲65歲或以上的長者八達通及樂悠咭持有人提供免費乘搭港鐵、輕鐵及港鐵巴士優惠。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.